New paper out! Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities by Brem et al.
The publication draws on findings and lessons learned from three IMI initiatives, RADAR-AD, IDEA-FAST and Mobilise-D to discuss:
- The value of remote technologies to assess neurodegenerative diseases
- Feasibility, acceptability and usability of digital assessments
- Challenges related to the use of digital tools
- Public involvement and the implementation of patient advisory boards
- Regulatory learnings
- The significance of inter-project exchange and data- and algorithm-sharing
To read the paper follow the link: doi.org/10.3389/fneur.2023.1210974
